Showing results (191-200 of 435) with videos related to

Sort By:
Pageof 44
Annals of Surgery|September 13, 2012
Adjuvant chemotherapy with FOLFOX for primary colorectal cancer is associated with increased somatic gene mutations and inferior survival in patients undergoing hepatectomy for metachronous liver metastasesAndreas Andreou, Scott Kopetz, Dipen M Maru, et al.
The Oncologist|June 13, 2023
A Phase I Trial of Bevacizumab and Temsirolimus in Combination With Valproic Acid in Advanced Solid TumorsBlessie Elizabeth Nelson, Apostolia M Tsimberidou, Xueyao Fu, et al.
Clinical Colorectal Cancer|October 14, 2009
Portal hypertension associated with oxaliplatin administration: clinical manifestations of hepatic sinusoidal injuryJulian H Slade, Mona L Alattar, David R Fogelman, et al.
Cancer Research|April 23, 2009
Synergistic activity of the SRC family kinase inhibitor dasatinib and oxaliplatin in colon carcinoma cells is mediated by oxidative stressScott Kopetz, Donald P Lesslie, Nikolas A Dallas, et al.
Nature Medicine|July 31, 2025
Precemtabart tocentecan, an anti-CEACAM5 antibody-drug conjugate, in metastatic colorectal cancer: a phase 1 trialScott Kopetz, Valentina Boni, Ken Kato, et al.
JCO Precision Oncology|January 20, 2022
International Harmonization of Provisional Diagnostic Criteria for ERBB2-Amplified Metastatic Colorectal Cancer Allowing for Screening by Next-Generation Sequencing PanelSatoshi Fujii, Anthony M Magliocco, Jihun Kim, et al.
Oncotarget|May 12, 2016
Efficacy of the combination of MEK and CDK4/6 inhibitors in vitro and in vivo in KRAS mutant colorectal cancer modelsMichael S Lee, Timothy L Helms, Ningping Feng, et al.
Oncotarget|February 29, 2020
Identification of biomarkers of immune checkpoint blockade efficacy in recurrent or refractory solid tumor malignanciesRichard K Yang, Yun Qing, Fatima Zahra Jelloul, et al.
Annals of Surgical Oncology|June 17, 2010
Long-term survival and recurrence outcomes following surgery for distal rectal cancerEric J Silberfein, Kiran M Kattepogu, Chung-Yuan Hu, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|November 2, 2013
FXR silencing in human colon cancer by DNA methylation and KRAS signalingAnn M Bailey, Le Zhan, Dipen Maru, et al.
Pageof 44